Aptamer Group signs agreement with Timser Group for cervical cancer diagnostic
LONDON: Aptamer Group plc (AIM: APTA), a developer of novel Optimer® binders for the life sciences industry, has entered into an agreement with Timser Group, a pharmaceutical company specializing in women’s health. The deal, valued at up to £465,000, aims…